<DOC>
	<DOCNO>NCT01548248</DOCNO>
	<brief_summary>This study conduct Europe . The aim study evaluate efficacy safety insulin detemir ( Levemir® ) use basal insulin glycaemic control , weight incidence hypoglycaemic event insulin treat subject type 1 type 2 diabetes treat insulin NPH normal clinical practice condition Slovakia .</brief_summary>
	<brief_title>Efficacy Safety Levemir® Used Basal Insulin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Type 1 type 2 diabetes treat insulin NPH</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>